https://oxidopamineantagonist.....com/multidisciplinar
BACKGROUND Mantle cell lymphoma (MCL) is a B cellular malignancy that may be aggressive in accordance with a poor prognosis; the clinical course is heterogeneous. The epidemiology of MCL in Asia is certainly not well documented but appears to include 2-6% of most lymphoma cases according to readily available information, with difference seen between countries. Although intercontinental recommendations are offered for the treatment of MCL, there is certainly a
Like
Comment
Share
